Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Lung Neoplasms 1 Endometrial Neoplasms 1

Interventions

Carboplatin 29 pembrolizumab 25 Pemetrexed 25 Specimen Handling 22 Cisplatin 20 Magnetic Resonance Spectroscopy 18 Paclitaxel 15 Gemcitabine 13 Docetaxel 12 durvalumab 10 Nivolumab 8 osimertinib 7 Taxes 7 Immunoglobulin G 7 Disulfides 7 130-nm albumin-bound paclitaxel 7 atezolizumab 6 Etoposide 6 Platinum 5 Cetuximab 5 1,2-diaminocyclohexaneplatinum II citrate 5 X-Rays 4 Ramucirumab 4 Radiotherapy 4 Radiation 4 Observation 4 Interviews as Topic 4 Biopsy 4 Albumin-Bound Paclitaxel 4 patritumab deruxtecan 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Neoplasms × CP protocol × 30 days × Clear all

NCT05061550 2026-05-22

NeoCOAST-2

AstraZeneca

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡